Abstract
INTRODUCTION
Hypoplastic left heart syndrome (HLHS) is characterized by underdeveloped left-sided heart structures insufficient to sustain the systemic circulation. Surgical intervention for HLHS includes 3 surgical stages culminating in the Fontan procedure. In the initial stage of palliation, 2 types of surgical techniques have been used to provide pulmonary blood flow: the modified Blalock-Taussig (BT) shunt, which connects the innominate or subclavian artery to the pulmonary artery and the right ventricle to pulmonary artery (RV-PA) conduit. There are potential advantages and disadvantages in both shunt types. Progressive RV dysfunction is a major risk factor for morbidity and mortality in children with HLHS [1] [2] [3] .
Quantitative echocardiographic assessment of systemic RV function in HLHS has been difficult due to the complex anatomy and morphology of the RV. Velocity vector imaging (VVI) is an echocardiographic technique based on speckle and contour tracking. VVI measures myocardial velocities, myocardial deformation and mechanical synchrony. It is independent of angle of insonation and the geometry of the ventricle. VVI has been validated by magnetic resonance imaging for the assessment of RV systolic function in patients with HLHS [4] .
In the present study, we investigated the impact of the initial shunt type on the outcome of patients with HLHS, with a specific focus on detailed RV systolic performance and volume load evaluated with VVI through the 3 surgical stages of single ventricle palliation.
MATERIALS AND METHODS

Patients
This retrospective study was carried out at the Children's Hospital, University of Helsinki, Helsinki, Finland. All paediatric cardiac surgery in Finland is centralized in Helsinki, and this study population represents the national cohort of consecutive patients with HLHS who underwent Norwood procedure between January 2003 and December 2010. There were no patients with major extracardiac anomalies or chromosomal abnormalities. The study was approved by the hospital research committee and ethical board.
We divided the patients into 2 groups according to the type of shunt used in the Norwood procedure: BT shunt or RV-PA conduit. Patients were examined at 4 time points immediately prior to surgical stages: Stage 1 (Norwood) operation, Stage 2 (bidirectional Glenn shunt), Stage 3 (total cavopulmonary connection) and at the last follow-up 0.5-3 years after Stage 3. All patients were followed up until death or the end of the study period. All infants were divided into 3 HLHS anatomic subtypes according to the morphology of the mitral and aortic valves: mitral and aortic stenosis (MS/AS), mitral stenosis and aortic atresia (MS/AA) and mitral and aortic atresia (MA/AA).
During the study period, the operative approach for HLHS patients in our hospital included a Norwood procedure in the neonatal period, Stage 2 palliation at the age of 2-6 months and Stage 3 operation at the age of 2-4 years. Contraindications for Norwood procedure included prematurity, birthweight under 2.5 kg, severe tricuspid insufficiency or severe myocardial dysfunction. During the study period, the type of shunt was chosen according to the institutional policy, in a way that only 1 shunt type was performed during a specific time period and both shunt types were equally performed for high-risk patients. A BT shunt was used between January 2003 and October 2003 and between August 2006 and March 2010. An RV-PA conduit was used during other time periods of the study era. The ventriculotomy for the RV-PA conduit was performed in the RV infundibulum. The incision was made with a knife and enlarged by retracting the muscle fibres with the tip of the scissors. The proximal end of the shunt was inserted through the ventriculotomy inside the cavity and fixed with a purse string suture and a stitch. Antegrade cerebral perfusion in moderate hypothermia (20) (21) (22) (23) (24) C) and cold blood cardioplegia were used in all patients. At Stage 2 operation, the proximal Gore-Tex conduit was ligated in all patients with an RV-PA conduit. The ventriculotomy was not closed in any of them. All operations were performed by 4 experienced staff surgeons.
Clinical variables
Medical records were reviewed for demographic, anatomical and clinical characteristics and operative data. Clinical details included weight, oxygen saturation, blood pressure and cardiac medications at the time of echocardiography evaluation. Operative data included aortic cross-clamp time, cardiopulmonary bypass time, duration of ventilation, length of intensive care stay, duration of pleural effusions and duration of hospitalization. Additional procedures performed at bidirectional Glenn shunt and total cavopulmonary connection operations or during the study period were also noted. Additionally, data were collected from reports of cardiac catheterizations performed before Stages 2 and 3 and 0.5-3 years after Stage 3.
Cardiac evaluations
Cardiac function was evaluated retrospectively utilizing an Xcelera (Philips Healthcare, Eindhoven, Netherlands) database of stored echocardiographic images. Echocardiographic examinations had been evaluated immediately prior to the surgical Stages 1, 2 and 3 and 0.5-2.7 years after Stage 3. These images had been recorded according to a standardized ultrasound protocol. The severity of tricuspid and neoaortic valve regurgitation was classified as haemodynamically significant (moderate or severe) or insignificant (none, trivial or mild).
For functional analysis, echocardiographic data were transferred in DICOM format to the VVI analysing program (Syngo USWP 3.0, Siemens Healthineers, Erlangen, Germany). The data were then stored in a research archive with code numbers. RV FAC values, end-diastolic and end-systolic area/body surface area (BSA) ratio, global (average of 6 segments) and regional peak systolic longitudinal strain (S) and strain rate (SR) as well as mechanical synchrony were analysed from the apical 4-chamber view as described previously with acceptable intra-and interobserver reliability [4, 5] . The degree of mechanical dyssynchrony was quantified using the standard deviation of the time to peak strain between 6 different cardiac segments divided by square root of duration of cardiac cycle [6] . The size of the left ventricle (LV) was measured from the apical 4-chamber view using auto left heart algorithm. One investigator (H.R.), blinded to all clinical data, performed all functional analyses.
Statistical analysis
Clinical demographics and global cardiac functional data for study groups were compared using the t-test or Mann-Whitney U-test test for continuous parameters, Cochran-Mantel-Haenszel test for noncontinuous parameters and Fisher's exact test or Pearson's v 2 test for frequencies. Bonferroni-corrected t-tests were used for repeated analysis. Logarithmic transformation was used to normalize skewed distributions for the t-tests and multiple regression analysis. Correlations (R) were calculated using the Pearson's correlation coefficient for normally distributed data and the Spearman's rank correlation coefficient for skewed distributions. Multiple regression analysis was used to find factors affecting myocardial function measured by FAC. The covariates in the initial model included shunt type, stage of palliation, existence of prenatal diagnosis, size of LV, cardiopulmonary bypass time, dys-synchrony index, blood pressure, saturation and existence of fenestration. All these factors were also assessed separately at different stages of treatment protocol. Kolmogorov-Smirnov test with Lilliefors' significance correction was used to test normality of parameters. A P-value of <0.05 was used to define significance. SPSS for Windows version 19.0 (SPSS Inc/IBM Corporation, Somers, NY, USA) was used to perform these statistical analyses.
RESULTS
Twenty-three children were palliated with a BT shunt and 40 with an RV-PA conduit over the study period. A flow chart of patient outcomes through the surgical stages is presented in Fig. 1 . Twenty-four (38.1%) infants had prenatal HLHS diagnosis. All infants with prenatal diagnosis were born in the Helsinki University Hospital. Children without prenatal diagnosis were born in delivery hospitals throughout Finland and were then transported to Helsinki. There were no differences in the frequency of prenatal diagnosis, HLHS anatomic subtype, gestational age, preoperative haemodynamics or birthweight between study groups (Table 1) .
Operative data
At Stage 1 operation, cardiopulmonary bypass time and aortic cross-clamp time were longer in the RV-PA group. In the RV-PA group, a 6-mm conduit was used in all patients (Table 1 ). In the BT group, shunt size was 3.5 mm in 9 (39%) and 4 mm in 14 (61%) patients. There were no differences in the duration of ventilation, length of intensive care unit stay or length of hospital stay between the groups (Table 1) .
Stage 2 palliation was performed earlier in the BT group largely due to clinical deterioration in these patients. Clinical deterioration included severe desaturation or pulmonary overcirculation and heart failure. At the time of Stage 2 operation, patients with BT shunts demonstrated lower weight, but no difference in weight centile (data not shown) was observed. Both systolic and diastolic blood pressures were lower in patients with a BT shunt at the time of Stage 2 operation (81.4 ± 12.4/43.4 ± 10.2 mmHg vs 93.7 ± 11.6/ 53.5 ± 8.8 mmHg, P = 0.005/0.003). During the Stage 2 operation, cardiopulmonary bypass was used for all patients in both groups. No differences in cardiopulmonary bypass or aortic cross-clamp times were observed between groups. The BT group patients had slower postoperative recovery. There were no other differences in clinical data or operative factors during Stage 2 (Table 1) .
At Stage 3 operation, there were no differences between groups in clinical data. Cardiopulmonary bypass time was longer in the BT group (Table 1) . A fenestration was created in all patients. Postoperatively, duration of pleural and/or visceral effusions were longer in the BT group (30 ± 15 days vs 15 ± 12 days, P = 0.03), and length of hospital stay tended to be longer in the BT group, but this did not reach statistical significance (34 ± 32 vs 21 ± 12 days, P = 0.06). Spontaneous closure of the Fontan fenestration was observed in 44% of the patients during follow-up with no difference between groups. Cumulative total cardiopulmonary bypass time during the whole study period was 286 ± 146 min in the BT group and 323 ± 121 min in the RV-PA group (P = 0.3). Recoarctation incidence was 24% during the study period, 10 patients were operated on and 6 patients underwent balloon angioplasty with no difference between the groups (P = 0.9).
Mortality
Overall mortality during the study period was 19.0%. All mortality occurred either at interstage period between Stages 1 and 2 or before Stage 3 surgical procedure ( Table 2 ). All non-survivors had lower myocardial function before Stage 2 when compared with those who survived until Stage 3 (n = 51) (FAC 15.7 ± 6.0% vs 23.7 ± 6.8%, P = 0.03). Therefore, all systolic myocardial functional statistical analyses were performed both with and without nonsurvivors. No differences in final results were observed. None of the patients underwent cardiac transplantation.
Echocardiography
At baseline, no differences in FAC, S, SR or area measurements were detected between groups (P > 0.1, Fig. 2) . Preoperatively, infants diagnosed prenatally had better myocardial function than those with postnatal diagnosis (FAC 27.9 ± 7.4% vs 21.1 ± 6.3%, P = 0.0004). Poor myocardial function (FAC <16%, <-2 SD in study population) was detected in 5 patients in both groups. At baseline, the incidence of moderate tricuspid valve regurgitation was similar in both groups. None of the patients had severe tricuspid valve regurgitation.
After Stage 1 operation, systolic and diastolic RV area/BSA ratios were higher and FAC lower in the BT group (Fig. 2 , see Supplementary Material, Table S3 ). No differences were detected in S or SR at this stage between groups. Significant tricuspid valve regurgitation was more common in the BT group before Stage 2 operation (Figs 2 and 3 ). After Stage 2 operation, there was no difference in the incidence of significant tricuspid valve regurgitation or RV area/BSA ratio between groups (Figs 2 and 3) . Tricuspid valvuloplasty was performed in 7 (30%) patients in the BT group and in 6 (15%, P = 0.1) in the RV-PA group during the study period.
After Stage 2, a more distinct increase in systolic myocardial functional measurements was observed in the BT group. At the last follow-up, 6 to 32 months after Stage 3 palliation, all systolic myocardial functional measurements were higher in the BT group (Fig. 2 , see Supplementary Material, Table S3 ). There was no difference between groups in regional S or SR measurements or in mechanical synchrony at any time point. No correlation was detected between myocardial dys-synchrony and myocardial function (r < 0.5, P > 0.3). The patient's age during Stage 2 operation had no correlation with RV area/BSA, FAC, S, SR or dys-synchrony index at any stage after Stage 2 palliation.
In multiple stepwise regression analysis, shunt type and stage of palliation were the only characteristics remaining in the final model. Before the Stage 1 operation, FAC was higher in children with prenatal diagnosis and the LV size had a negative impact on FAC values (data not shown). These differences disappeared after the Stage 1 operation. Blood pressures, oxygen saturations or fenestrations were not associated with myocardial function at any stage (P > 0.05). In the final model, stage of palliation and initial shunt type had an association with myocardial function measured by FAC (regression coefficient ß1 41.4 (95% confidence interval 27.8-55.3, P = 0.004). Direction of the association between shunt type and myocardial function changed during the treatment protocol: between Stages 1 and 2, FAC was higher in patients with an RV-PA conduit, and, thereafter, FAC, S and SR were higher in patients with a BT shunt.
Cardiac catheterization
In cardiac catheterization performed before Stage 2 palliation in 16 (70.0%) patients in the BT group and 36 (90%) in the RV-PA group (P = 0.6), higher end-diastolic RV pressure (7.7 ± 2.4 vs 6.5 ± 1.5 mmHg, P = 0.04) and lower diastolic pressure in the aortic arch (34.8 ± 5.9 vs 40.6 ± 9.1 mmHg, P = 0.03) were observed in the BT group. Before Stage 3 palliation, catheterization was performed in all patients in both groups. In median, 2 years after Stage 3, catheterization was performed in 10 patients (58.8%) in the BT group and 23 (70.0%) in the RV-PA group (P = 0.8). There were no differences between groups in the size of pulmonary arteries or McGoon index at any stage (see Supplementary Material, Table S4 ).
DISCUSSION
RV myocardial function plays a critical role in the long-term outcomes of patients with HLHS. Impaired myocardial function has Additional procedures included tricuspid valvuloplasty, pulmonary artery reconstruction and aortic arch repair. Mean ± SD/median (range)/n (%). HLHS: hypoplastic left heart syndrome; BT: Blalock-Taussig; RV-PA: right ventricle to pulmonary artery; ICU: intensive care unit. been recognized as a major risk factor for mortality and need for cardiac transplantation [1-3, 7, 8] . Risk factors for poor myocardial function remain incompletely understood. In this study, the shunt type at the initial stage of palliation was associated with myocardial systolic function throughout the surgical stages. Immediately after Stage 1 palliation, the BT shunt was associated with higher systolic and diastolic RV area/BSA ratios and lower FAC. It was also associated with a tendency to higher mortality and worse clinical condition, necessitating earlier Stage 2 palliation. This is in keeping with other reports suggesting that an RV-PA conduit may be better tolerated through Stage 1 palliation [8] and associated with better myocardial function at that stage [1, 9, 10] . Chronic volume load and diastolic steal affecting coronary perfusion, occurring after Stage 1 procedure in patients with a BT shunt [10, 11] may have contributed to lower FAC [11] [12] [13] [14] . Although other possible mechanisms for this difference may include differences in contraction pattern, myocardial ischaemia and contraction dys-synchrony, we did not find differences between groups in dys-synchrony, peak systolic longitudinal strain or SR measurements following Stage 1 palliation. Some of our observations may have been related to volume load because infants with a BT shunt at initial palliation demonstrated more significant tricuspid insufficiency with a tendency to more frequent need of valvuloplasty. Although our assumption was that the lower FAC detected in the BT group suggested impaired systolic function, an alternative explanation may be that a larger volume loaded ventricle may not need to contract as much as a smaller ventricle to generate the same stroke volume. This could explain the lack of differences in other, perhaps less load-dependent, parameters of function.
Despite the early association of worse clinical status and tendency for higher mortality, initial palliation with a BT shunt was later associated with better RV systolic performance following the subsequent surgical stages. Similarly, in a randomized trial by Frommelt and co-workers, RV size increased and ejection fraction decreased in the RV-PA group after Stage 2 palliation [15] . They also showed abnormal circumferential deformation for the RV-PA group in the area of ventriculotomy and raised a need for longer RV deformation assessment studies in survivors after the Norwood procedure [16] . Furthermore, in a randomized study [2] comparing outcomes in children with different shunt types, the BT shunt group demonstrated better myocardial function than children in RV-PA group at the age of 3. Other studies in patients after Stage 3 have shown conflicting results [10, 17, 18] . The impact of the initial shunt type may be related to several factors. The size of the shunt may influence myocardial function. The larger the shunt, the greater the early volume load, but it could also contribute to the presence of a larger myocardial scar in RV-PA patients. The timing of the Stage 2 operation and thereby the time spent in the challenging haemodynamic condition at Stage 1 may also play a role in patients with an RV-PA conduit having later Stage 2 procedures. Further, the surgical technique used to place the RV-PA conduit and to close it at Stage 2 may be crucial. In our study, during the Stage 2 operation in the RV-PA group, the conduit was ligated and the ventriculotomy was not closed. Perhaps closure of the ventriculotomy could have led to better longer term functional outcomes. Interestingly, to date, no study evaluating RV function in HLHS through surgical stages has explored the impact of different approaches to the RV-PA conduit both, at initial shunt insertion and Stage 2 palliation [2, 10, [15] [16] [17] [18] .
Previously, the LV size and anatomical subtype of HLHS have been shown to have an effect on myocardial function at later stages of surgical palliation particularly in ventricular septal function, but less so in global function [19] . We did not find LV size and HLHS subtype to be associated with RV function following any of the surgical stages, but it did affect RV function prior to the Stage 1 operation. Finally, a total cavopulmonary connection fenestration may have a positive effect on function by improving ventricular loading, but its long-term effects on myocardial function are poorly understood. In this study, fenestrations were used in all patients, and patency of fenestration at the last assessment was not different between groups. Furthermore, both strain and SR-a load-independent measure of systolic performance [20] were different between groups, suggesting that our findings after Stage 3 palliation truly reflected differences in myocardial contractility and not just loading conditions. Overall, 80% survival was observed during the study period, which is comparable to other reports [2] . In a randomized trial comparing shunt types in HLHS patients [1, 3] transplantation-free survival was better in children with an RV-PA conduit than in those with a BT shunt during the first year after Norwood operation. However, at the age of 3, no difference in mortality was observed between groups [2] . We observed most deaths before Stage 2 with no differences between groups. The mortality was associated with poor myocardial function between Stages 1 and 2. However, when performing systolic myocardial functional analyses both with and without non-survivors, no differences in the final results were observed.
Study limitations and strengths
The major limitation of the present study was the lack of a nonrandomized design. However, the decision as to the type of the shunt at the time of Stage 1 palliation was based on the date of birth, regardless of the clinical or echocardiographic findings, and varied throughout the study period. Also myocardial function and incidence of significant tricuspid insufficiency were similar in both groups before the Norwood operation and there was also similar frequency of patients with prenatal diagnosis in both groups. Four staff surgeons performed all operations, and surgical mortality did not change for any of the stages over the study period. As a strength, the cohort examined in the present study in fact represented a complete national cohort of consecutive patients managed in a single surgical center.
CONCLUSIONS
Initial shunt type at Stage 1 palliation affects RV systolic performance in children with HLHS throughout the surgical stages of palliation. Although following Stage 1 palliation, RV FAC is initially lower in infants with a BT shunt, potentially reflecting either reduced systolic function or normalization of function in the context of a larger RV, after Stage 3, having had a BT shunt at the initial stage is associated with better RV systolic performance. Differences in RV systolic performance may be due, at least in part, to greater time spent prior to Stage 2 with volume overload and the impact of myocardial scarring in infants palliated initially with an RV-PA conduit.
